← FDA DRUG APPROVALS

FDA ANDA · ANDA078969

GRANISETRON HYDROCHLORIDE

Sponsor: NATCO PHARMA

APPLICATION
ANDA078969
TYPE
ANDA
ORIGINAL APPROVAL
2009-06-22
LATEST ACTION
2022-08-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

GRANISETRON HYDROCHLORIDEPrescription
GRANISETRON HYDROCHLORIDE EQ 1MG BASE · TABLET · ORAL

Approval history

2022-08-22Labeling · Supplement 5 · standardAP
2022-08-22Labeling · Supplement 6 · standardAP
2022-08-22Labeling · Supplement 4 · standardAP
2014-10-17Labeling · Supplement 3 · standardAP
2011-12-07Labeling · Supplement 1AP
2009-06-22OriginalOtherAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →